Structure

Physi-Chem Properties

Molecular Weight:  298.19
Volume:  333.205
LogP:  4.492
LogD:  4.043
LogS:  -4.142
# Rotatable Bonds:  1
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.808
Synthetic Accessibility Score:  3.882
Fsp3:  0.55
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.094
MDCK Permeability:  2.272952042403631e-05
Pgp-inhibitor:  0.988
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.016
20% Bioavailability (F20%):  0.471
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.161
Plasma Protein Binding (PPB):  96.9549560546875%
Volume Distribution (VD):  1.234
Pgp-substrate:  4.339424133300781%

ADMET: Metabolism

CYP1A2-inhibitor:  0.819
CYP1A2-substrate:  0.881
CYP2C19-inhibitor:  0.545
CYP2C19-substrate:  0.904
CYP2C9-inhibitor:  0.496
CYP2C9-substrate:  0.946
CYP2D6-inhibitor:  0.441
CYP2D6-substrate:  0.856
CYP3A4-inhibitor:  0.501
CYP3A4-substrate:  0.681

ADMET: Excretion

Clearance (CL):  13.081
Half-life (T1/2):  0.382

ADMET: Toxicity

hERG Blockers:  0.116
Human Hepatotoxicity (H-HT):  0.233
Drug-inuced Liver Injury (DILI):  0.079
AMES Toxicity:  0.021
Rat Oral Acute Toxicity:  0.421
Maximum Recommended Daily Dose:  0.943
Skin Sensitization:  0.239
Carcinogencity:  0.349
Eye Corrosion:  0.004
Eye Irritation:  0.534
Respiratory Toxicity:  0.96

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC259703

Natural Product ID:  NPC259703
Common Name*:   Hypargenin D
IUPAC Name:   (4aS,10aR)-6-hydroxy-1,1,4a-trimethyl-7-propan-2-yl-4,10a-dihydro-3H-phenanthren-2-one
Synonyms:   hypargenin D
Standard InCHIKey:  CRJHOCWYQXGNFV-FXAWDEMLSA-N
Standard InCHI:  InChI=1S/C20H26O2/c1-12(2)14-10-13-6-7-17-19(3,4)18(22)8-9-20(17,5)15(13)11-16(14)21/h6-7,10-12,17,21H,8-9H2,1-5H3/t17-,20+/m0/s1
SMILES:  CC(C)c1cc2C=C[C@H]3C(C)(C)C(=O)CC[C@]3(C)c2cc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL487019
PubChem CID:   44559795
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26904 Salvia hypargeia Species Lamiaceae Eukaryota roots n.a. n.a. PMID[3236010]
NPO26904 Salvia hypargeia Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 62.5 ug.mL-1 PMID[491881]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ > 7.0 mm PMID[491881]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis IZ > 7.0 mm PMID[491881]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa IZ > 7.0 mm PMID[491881]
NPT79 Organism Bacillus subtilis Bacillus subtilis IZ > 7.0 mm PMID[491881]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae IZ > 7.0 mm PMID[491881]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC259703 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC32322
0.9739 High Similarity NPC154696
0.9487 High Similarity NPC176208
0.9483 High Similarity NPC241001
0.9407 High Similarity NPC471187
0.9402 High Similarity NPC162935
0.9402 High Similarity NPC249340
0.9328 High Similarity NPC181334
0.9322 High Similarity NPC121168
0.9322 High Similarity NPC11250
0.9256 High Similarity NPC72667
0.9244 High Similarity NPC198014
0.9237 High Similarity NPC253627
0.9231 High Similarity NPC190501
0.9231 High Similarity NPC318552
0.9204 High Similarity NPC250323
0.9174 High Similarity NPC71610
0.9174 High Similarity NPC254492
0.9167 High Similarity NPC199273
0.9145 High Similarity NPC42657
0.9106 High Similarity NPC171460
0.9106 High Similarity NPC276238
0.9098 High Similarity NPC69424
0.9098 High Similarity NPC84672
0.9098 High Similarity NPC176130
0.9098 High Similarity NPC78364
0.9091 High Similarity NPC137750
0.9091 High Similarity NPC87985
0.9068 High Similarity NPC478121
0.9027 High Similarity NPC13482
0.9024 High Similarity NPC96024
0.8983 High Similarity NPC258366
0.8983 High Similarity NPC31296
0.8983 High Similarity NPC473974
0.8983 High Similarity NPC79933
0.8974 High Similarity NPC477136
0.8947 High Similarity NPC176279
0.8947 High Similarity NPC260323
0.8889 High Similarity NPC165612
0.8889 High Similarity NPC471668
0.888 High Similarity NPC108129
0.8879 High Similarity NPC195922
0.886 High Similarity NPC141782
0.8852 High Similarity NPC75432
0.8843 High Similarity NPC282577
0.8833 High Similarity NPC164852
0.881 High Similarity NPC471851
0.8803 High Similarity NPC192948
0.8803 High Similarity NPC35797
0.88 High Similarity NPC303910
0.877 High Similarity NPC273683
0.8761 High Similarity NPC228737
0.8761 High Similarity NPC151477
0.8739 High Similarity NPC328694
0.8729 High Similarity NPC308311
0.8729 High Similarity NPC477137
0.8729 High Similarity NPC219112
0.8729 High Similarity NPC38893
0.872 High Similarity NPC3009
0.8718 High Similarity NPC268160
0.8707 High Similarity NPC46940
0.8707 High Similarity NPC286222
0.8699 High Similarity NPC15127
0.8673 High Similarity NPC21594
0.8672 High Similarity NPC78307
0.8672 High Similarity NPC138472
0.8672 High Similarity NPC477139
0.8667 High Similarity NPC93071
0.8661 High Similarity NPC476847
0.8655 High Similarity NPC172219
0.8655 High Similarity NPC304510
0.8651 High Similarity NPC131684
0.8651 High Similarity NPC206028
0.8644 High Similarity NPC147179
0.864 High Similarity NPC30491
0.864 High Similarity NPC262936
0.8632 High Similarity NPC715
0.8629 High Similarity NPC123506
0.8621 High Similarity NPC470770
0.8621 High Similarity NPC95716
0.8621 High Similarity NPC266937
0.8609 High Similarity NPC58865
0.8605 High Similarity NPC202225
0.8584 High Similarity NPC117115
0.8583 High Similarity NPC154030
0.8583 High Similarity NPC471671
0.8571 High Similarity NPC308828
0.8571 High Similarity NPC469663
0.8571 High Similarity NPC92
0.8547 High Similarity NPC62867
0.8547 High Similarity NPC177962
0.8538 High Similarity NPC153088
0.8527 High Similarity NPC49742
0.8527 High Similarity NPC111845
0.8525 High Similarity NPC21216
0.8522 High Similarity NPC11554
0.8516 High Similarity NPC291001
0.8516 High Similarity NPC243305
0.8512 High Similarity NPC126002
0.8512 High Similarity NPC469644
0.8504 High Similarity NPC117899
0.85 High Similarity NPC16030
0.8492 Intermediate Similarity NPC471530
0.8487 Intermediate Similarity NPC469719
0.8468 Intermediate Similarity NPC275145
0.8462 Intermediate Similarity NPC77772
0.8462 Intermediate Similarity NPC151537
0.8462 Intermediate Similarity NPC322753
0.8438 Intermediate Similarity NPC253488
0.843 Intermediate Similarity NPC469609
0.8425 Intermediate Similarity NPC48248
0.8425 Intermediate Similarity NPC193203
0.8413 Intermediate Similarity NPC269598
0.8409 Intermediate Similarity NPC36868
0.8409 Intermediate Similarity NPC475957
0.8409 Intermediate Similarity NPC53001
0.84 Intermediate Similarity NPC173978
0.84 Intermediate Similarity NPC474766
0.8397 Intermediate Similarity NPC283088
0.839 Intermediate Similarity NPC228425
0.8387 Intermediate Similarity NPC307174
0.8387 Intermediate Similarity NPC478058
0.8385 Intermediate Similarity NPC476282
0.8385 Intermediate Similarity NPC53896
0.8376 Intermediate Similarity NPC132720
0.8376 Intermediate Similarity NPC296683
0.8372 Intermediate Similarity NPC244699
0.8372 Intermediate Similarity NPC474517
0.8372 Intermediate Similarity NPC72669
0.8372 Intermediate Similarity NPC18798
0.8359 Intermediate Similarity NPC146647
0.8359 Intermediate Similarity NPC34414
0.8346 Intermediate Similarity NPC230811
0.8346 Intermediate Similarity NPC87723
0.8333 Intermediate Similarity NPC120693
0.8333 Intermediate Similarity NPC8931
0.8333 Intermediate Similarity NPC261573
0.8333 Intermediate Similarity NPC471670
0.8321 Intermediate Similarity NPC12070
0.8321 Intermediate Similarity NPC293454
0.8321 Intermediate Similarity NPC50924
0.8321 Intermediate Similarity NPC27394
0.8308 Intermediate Similarity NPC58685
0.8305 Intermediate Similarity NPC471188
0.8295 Intermediate Similarity NPC470725
0.8293 Intermediate Similarity NPC260832
0.8293 Intermediate Similarity NPC135467
0.8291 Intermediate Similarity NPC314187
0.8281 Intermediate Similarity NPC229894
0.8276 Intermediate Similarity NPC320439
0.8271 Intermediate Similarity NPC277559
0.8268 Intermediate Similarity NPC3224
0.8264 Intermediate Similarity NPC477453
0.8264 Intermediate Similarity NPC141001
0.8258 Intermediate Similarity NPC249272
0.8258 Intermediate Similarity NPC103082
0.8254 Intermediate Similarity NPC142956
0.8254 Intermediate Similarity NPC164014
0.825 Intermediate Similarity NPC471534
0.8244 Intermediate Similarity NPC475627
0.8244 Intermediate Similarity NPC475457
0.8244 Intermediate Similarity NPC18982
0.8244 Intermediate Similarity NPC475346
0.8244 Intermediate Similarity NPC114183
0.8244 Intermediate Similarity NPC115458
0.824 Intermediate Similarity NPC164947
0.824 Intermediate Similarity NPC152946
0.8235 Intermediate Similarity NPC471179
0.8231 Intermediate Similarity NPC239134
0.8231 Intermediate Similarity NPC85342
0.823 Intermediate Similarity NPC225506
0.823 Intermediate Similarity NPC211885
0.8226 Intermediate Similarity NPC474175
0.8226 Intermediate Similarity NPC190971
0.822 Intermediate Similarity NPC95126
0.822 Intermediate Similarity NPC475002
0.8217 Intermediate Similarity NPC25736
0.8217 Intermediate Similarity NPC99731
0.8211 Intermediate Similarity NPC151197
0.8211 Intermediate Similarity NPC182240
0.8197 Intermediate Similarity NPC299180
0.8195 Intermediate Similarity NPC472308
0.819 Intermediate Similarity NPC188677
0.819 Intermediate Similarity NPC271274
0.8189 Intermediate Similarity NPC4286
0.8189 Intermediate Similarity NPC76119
0.8182 Intermediate Similarity NPC213122
0.8182 Intermediate Similarity NPC472262
0.8182 Intermediate Similarity NPC270899
0.8182 Intermediate Similarity NPC287604
0.8182 Intermediate Similarity NPC161964
0.8175 Intermediate Similarity NPC478164
0.8175 Intermediate Similarity NPC135062
0.8174 Intermediate Similarity NPC238696
0.8168 Intermediate Similarity NPC312560
0.8167 Intermediate Similarity NPC317869
0.8167 Intermediate Similarity NPC322239
0.816 Intermediate Similarity NPC120545
0.8158 Intermediate Similarity NPC252105
0.8154 Intermediate Similarity NPC55949

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC259703 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9397 High Similarity NPD2932 Approved
0.9231 High Similarity NPD3019 Approved
0.8525 High Similarity NPD3026 Approved
0.8525 High Similarity NPD3023 Approved
0.8512 High Similarity NPD3024 Approved
0.8512 High Similarity NPD3025 Approved
0.8235 Intermediate Similarity NPD7635 Approved
0.8231 Intermediate Similarity NPD6663 Approved
0.8203 Intermediate Similarity NPD5736 Approved
0.816 Intermediate Similarity NPD1201 Approved
0.813 Intermediate Similarity NPD3091 Approved
0.812 Intermediate Similarity NPD2342 Discontinued
0.8065 Intermediate Similarity NPD1651 Approved
0.8 Intermediate Similarity NPD4059 Approved
0.7982 Intermediate Similarity NPD3020 Approved
0.7969 Intermediate Similarity NPD1283 Approved
0.7965 Intermediate Similarity NPD288 Approved
0.7926 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.792 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD1470 Approved
0.7876 Intermediate Similarity NPD1809 Phase 2
0.7876 Intermediate Similarity NPD844 Approved
0.7874 Intermediate Similarity NPD3092 Approved
0.7833 Intermediate Similarity NPD4750 Phase 3
0.7823 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7794 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7788 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD8166 Discontinued
0.777 Intermediate Similarity NPD7003 Approved
0.7759 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD6099 Approved
0.7737 Intermediate Similarity NPD6100 Approved
0.7737 Intermediate Similarity NPD5405 Approved
0.7737 Intermediate Similarity NPD5406 Approved
0.7737 Intermediate Similarity NPD5408 Approved
0.7737 Intermediate Similarity NPD5404 Approved
0.7734 Intermediate Similarity NPD1281 Approved
0.7719 Intermediate Similarity NPD2859 Approved
0.7719 Intermediate Similarity NPD2860 Approved
0.7717 Intermediate Similarity NPD3095 Discontinued
0.7717 Intermediate Similarity NPD4626 Approved
0.7699 Intermediate Similarity NPD845 Approved
0.7687 Intermediate Similarity NPD8032 Phase 2
0.7686 Intermediate Similarity NPD3021 Approved
0.7686 Intermediate Similarity NPD3022 Approved
0.7661 Intermediate Similarity NPD5951 Approved
0.7634 Intermediate Similarity NPD3094 Phase 2
0.7632 Intermediate Similarity NPD2934 Approved
0.7632 Intermediate Similarity NPD2933 Approved
0.7615 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD7390 Discontinued
0.7589 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD2286 Discontinued
0.7578 Intermediate Similarity NPD1751 Approved
0.7518 Intermediate Similarity NPD4097 Suspended
0.75 Intermediate Similarity NPD4093 Discontinued
0.7481 Intermediate Similarity NPD1755 Approved
0.7442 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD3300 Phase 2
0.7402 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD3636 Approved
0.7388 Intermediate Similarity NPD3637 Approved
0.7388 Intermediate Similarity NPD3635 Approved
0.7372 Intermediate Similarity NPD2979 Phase 3
0.7372 Intermediate Similarity NPD4060 Phase 1
0.7368 Intermediate Similarity NPD1164 Approved
0.7364 Intermediate Similarity NPD5691 Approved
0.7333 Intermediate Similarity NPD2606 Approved
0.7333 Intermediate Similarity NPD2605 Approved
0.7313 Intermediate Similarity NPD2194 Approved
0.7313 Intermediate Similarity NPD2195 Approved
0.7313 Intermediate Similarity NPD4624 Approved
0.7308 Intermediate Similarity NPD4589 Approved
0.7308 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD2346 Discontinued
0.728 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD5156 Approved
0.7279 Intermediate Similarity NPD4625 Phase 3
0.7279 Intermediate Similarity NPD5155 Approved
0.7273 Intermediate Similarity NPD3972 Approved
0.7258 Intermediate Similarity NPD1792 Phase 2
0.725 Intermediate Similarity NPD846 Approved
0.725 Intermediate Similarity NPD940 Approved
0.7246 Intermediate Similarity NPD4140 Approved
0.7244 Intermediate Similarity NPD497 Approved
0.7239 Intermediate Similarity NPD2797 Approved
0.7234 Intermediate Similarity NPD2935 Discontinued
0.723 Intermediate Similarity NPD7458 Discontinued
0.7206 Intermediate Similarity NPD3594 Approved
0.7206 Intermediate Similarity NPD3595 Approved
0.7185 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD2798 Approved
0.7177 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD496 Approved
0.7165 Intermediate Similarity NPD2229 Approved
0.7165 Intermediate Similarity NPD495 Approved
0.7165 Intermediate Similarity NPD2234 Approved
0.7165 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD2228 Approved
0.7165 Intermediate Similarity NPD498 Approved
0.7164 Intermediate Similarity NPD6696 Suspended
0.7163 Intermediate Similarity NPD2799 Discontinued
0.7154 Intermediate Similarity NPD5304 Approved
0.7154 Intermediate Similarity NPD5303 Approved
0.7143 Intermediate Similarity NPD6273 Approved
0.7122 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD3620 Phase 2
0.7113 Intermediate Similarity NPD2531 Phase 2
0.7113 Intermediate Similarity NPD4477 Approved
0.7113 Intermediate Similarity NPD4476 Approved
0.7113 Intermediate Similarity NPD2438 Suspended
0.7109 Intermediate Similarity NPD2629 Approved
0.7101 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD3268 Approved
0.7101 Intermediate Similarity NPD3764 Approved
0.709 Intermediate Similarity NPD4749 Approved
0.709 Intermediate Similarity NPD5327 Phase 3
0.7083 Intermediate Similarity NPD2066 Phase 3
0.7068 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD7028 Phase 2
0.7059 Intermediate Similarity NPD3495 Discontinued
0.7054 Intermediate Similarity NPD256 Approved
0.7054 Intermediate Similarity NPD255 Approved
0.7049 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD1778 Approved
0.7042 Intermediate Similarity NPD7743 Approved
0.7042 Intermediate Similarity NPD7742 Approved
0.7037 Intermediate Similarity NPD1876 Approved
0.7034 Intermediate Similarity NPD3750 Approved
0.7031 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD7095 Approved
0.7025 Intermediate Similarity NPD1242 Phase 1
0.7023 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD1444 Approved
0.7016 Intermediate Similarity NPD1445 Approved
0.7015 Intermediate Similarity NPD1608 Approved
0.7009 Intermediate Similarity NPD1088 Approved
0.7007 Intermediate Similarity NPD4208 Discontinued
0.7 Intermediate Similarity NPD3226 Approved
0.7 Intermediate Similarity NPD7340 Approved
0.7 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD943 Approved
0.6991 Remote Similarity NPD111 Approved
0.6985 Remote Similarity NPD4339 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7004 Clinical (unspecified phase)
0.695 Remote Similarity NPD5735 Approved
0.695 Remote Similarity NPD6355 Discontinued
0.6947 Remote Similarity NPD7610 Discontinued
0.6944 Remote Similarity NPD4725 Approved
0.6944 Remote Similarity NPD4726 Approved
0.6944 Remote Similarity NPD4721 Approved
0.694 Remote Similarity NPD1611 Approved
0.6929 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6671 Approved
0.6923 Remote Similarity NPD3317 Approved
0.6918 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6918 Remote Similarity NPD7473 Discontinued
0.6918 Remote Similarity NPD4110 Phase 3
0.6911 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6911 Remote Similarity NPD1930 Approved
0.6911 Remote Similarity NPD1929 Approved
0.6906 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6906 Remote Similarity NPD7008 Discontinued
0.6901 Remote Similarity NPD6353 Approved
0.6901 Remote Similarity NPD1607 Approved
0.6899 Remote Similarity NPD1398 Phase 1
0.6894 Remote Similarity NPD7330 Discontinued
0.6891 Remote Similarity NPD1693 Approved
0.6891 Remote Similarity NPD688 Clinical (unspecified phase)
0.6889 Remote Similarity NPD4878 Approved
0.6884 Remote Similarity NPD2861 Phase 2
0.6857 Remote Similarity NPD6798 Discontinued
0.6857 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6849 Remote Similarity NPD3638 Discontinued
0.6849 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6846 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5585 Approved
0.6842 Remote Similarity NPD4235 Clinical (unspecified phase)
0.6838 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6838 Remote Similarity NPD1086 Approved
0.6838 Remote Similarity NPD1090 Approved
0.6838 Remote Similarity NPD1089 Approved
0.6835 Remote Similarity NPD4207 Discontinued
0.6835 Remote Similarity NPD6232 Discontinued
0.6828 Remote Similarity NPD2344 Approved
0.6825 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7819 Suspended
0.6812 Remote Similarity NPD257 Approved
0.6812 Remote Similarity NPD258 Approved
0.6807 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6806 Remote Similarity NPD651 Clinical (unspecified phase)
0.6803 Remote Similarity NPD4628 Phase 3
0.6803 Remote Similarity NPD3400 Discontinued
0.6791 Remote Similarity NPD17 Approved
0.679 Remote Similarity NPD5190 Phase 2
0.6783 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6781 Remote Similarity NPD970 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data